Global reach Paxman Scalp Cooling has a 25+ year track record and a clinically proven system, indicating a mature product with wide adoption potential across hospitals, chemotherapy clinics, and healthcare facilities worldwide.

Dual capacity The two-model Paxman Scalp Cooling System enables 1 or 2 patients to be treated independently, offering flexibility for hospitals with varying patient volumes and potential upsell to clinics that need scalable capacity.

Partnership network Extensive collaboration with global and regional organizations and a growing international distributor list suggest opportunities to expand channel partnerships, service support, and regional implementations.

Clinical value Clinically proven, cost-effective scalp cooling positioning supports conversations with procurement and oncology departments focused on improving patient outcomes and reducing chemotherapy-related alopecia-related distress.

Growth potential Established R&D focus and long-standing market presence indicate upside from expanding into new markets, additional training programs, and post-sale service packages to drive recurring revenue.